´Ý±â
TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.
Home > ÀüÁ¦Ç°º¸±â > ¼¼Æ÷¤ýÀ¯ÀüÀÚ Ä¡·á ¿¬±¸ > Overview > RetroNectin¢ç – Viral transduction, T-cell expansion Àû¿ë·Ê

RetroNectin¢ç – Viral transduction, T-cell expansion Àû¿ë·Ê

-

Application of RetroNectin¢ç (Recombinant Human Fibronectin Fragment)

What is RetroNectin?
RetroNectinÀº 3°³ÀÇ domain (cell-binding domain, heparin-binding domain, CS-1 sequence)À¸·Î ±¸¼ºµÈ ÀçÁ¶ÇÕ human fibronectin fragment (rFN-CH-296)ÀÌ´Ù.



[RetroNectin Á¦Ç°¸®½ºÆ®] - Á¦Ç° »ó¼¼º¸±â ¹Ù·Î°¡±â
Code

Á¦Ç°¸í

¿ë·®

T100A

RetroNectin (Recombinant Human Fibronectin Fragment)

0.5 mg (0.5 §¢)

T100B

RetroNectin (Recombinant Human Fibronectin Fragment)

2.5 mg (2.5 §¢)

T110A

RetroNectin Dish£¨RetroNectin Pre-coated Dish, 35 mm¥õ£©

10 dishes

T201

RetroNectin GMP grade Recombinant Human Fibronectin Fragment CH-296

2.5 mg


How does RetroNectin work?
RetroNectinÀº lentivirus ¶Ç´Â retrovirus¸¦ ÀÌ¿ëÇÑ À¯ÀüÀÚ µµÀԽà virus ÀÔÀÚ¿Í ¸ñÀû ¼¼Æ÷°£ÀÇ co-localizationÀ» µµ¿Í À¯ÀüÀÚ µµÀÔÈ¿À²À» ³ô¿©ÁØ´Ù. Virus ÀÔÀÚ¿Í RetroNectinÀÇ H-domain, RetroNectin°ú ¸ñÀû ¼¼Æ÷ÀÇ integrin receptor °£ °áÇÕ (¼¼Æ÷ÀÇ VLA-4¿Í fibronectin CS-1 site °£ °áÇÕ ¶Ç´Â ¼¼Æ÷ÀÇ VLA-5¿Í fibronectin C-domain °£ °áÇÕ)À¸·Î ¼¼Æ÷¿Í virus°¡ ¹°¸®ÀûÀ¸·Î °¡±î¿öÁüÀ¸·Î½á integrin receptors VLA-4 ¶Ç´Â VLA-5 ¹ßÇö ¼¼Æ÷ÀÇ viral-mediated gene transfer È¿À²À» ³ôÀÏ ¼ö ÀÖ´Ù.

  • VLA-4 ¹ßÇö¼¼Æ÷: T cells, B cells, ´ÜÇÙ¹éÇ÷±¸ (monocytes), NK cells, È£»ê±¸ (eosinophils), °ñ¼ö ´ÜÇÙ¼¼Æ÷ (bone marrow monocytic cells), ¸²ÇÁ±¸Àü±¸¼¼Æ÷ (lymphoid progenitor) µî
  • VLA-5 ¹ßÇö¼¼Æ÷: Èä¼±¼¼Æ÷ (thymocytes), activated T-cells, ºñ¸¸¼¼Æ÷ (mast cells) µî

[½ÇÇ迹 - 1] Àΰ£ Á¶Ç÷¸ð¼¼Æ÷ÀÇ retrovirus ¸Å°³ À¯ÀüÀÚ µµÀÔ: RetroNectin vs. Polybrene
Retrovirus¸¦ ÀÌ¿ëÇØ ³ì»öÇü±¤´Ü¹éÁú (GFP)À¯ÀüÀÚ¸¦ Àΰ£ Á¶Ç÷¸ð¼¼Æ÷¿¡ µµÀÔÇÑ °á°ú, RetroNectinÀ» ÀÌ¿ëÇÏ¿´À» ¶§ polybreneº¸´Ù ³ôÀº È¿À²·Î À¯ÀüÀÚ¸¦ µµÀÔÇÒ ¼ö ÀÖ¾ú´Ù. (Application Note PDF ´Ù¿î·Îµå)


±×¸². GFP gene transfer efficiency using either RetroNectin or polybrene.
A: Analysis of fluorescence by flow cytometry of CD34+ cells after retroviral transduction. GFP expression is plotted on the x-axis of the histograms.
B: Transduction efficiency, as determined by the percentage of CD34+ cells that express GFP, using either the polybrene method or the RetroNectin reagent method.

[½ÇÇ迹 - 2] Retrovirus¸¦ ÀÌ¿ëÇÑ Àΰ£ Áٱ⼼Æ÷ÀÇ À¯ÀüÀÚ µµÀÔ¹æ¹ý ºñ±³
Retrovirus¸¦ ÀÌ¿ëÇÏ¿© Àΰ£ Áٱ⼼Æ÷¿¡ Çü±¤´Ü¹éÁú À¯ÀüÀÚ¸¦ µµÀÔÇÒ ¶§ RetroNectin, Polybrene, ProtamineÀÇ À¯ÀüÀÚ µµÀÔÈ¿À²À» ºñ±³ÇÏ¿´´Ù.
RetroNectinÀ» ÀÌ¿ëÇÑ °æ¿ì, ´Ù¸¥ ¹æ¹ý¿¡ ºñÇØ ¹ÙÀÌ·¯½º µµÀÔÈ¿À²À» ºñ¾àÀûÀ¸·Î ³ôÀÏ ¼ö ÀÖ¾ú°í, ƯÈ÷ hCD34+, hADSC¿Í °°ÀÌ GaLV envelope receptor (Pit 1)ÀÇ ¹ßÇöÀÌ ³·Àº Áٱ⼼Æ÷¿¡¼­µµ À¯ÀüÀÚ µµÀÔÈ¿À²ÀÌ ³ôÀº °á°ú¸¦ È®ÀÎÇÏ¿´´Ù. (Application Note PDF ´Ù¿î·Îµå)


±×¸². Comparison of the efficiency of various transduction methods in human stem cells.

RetroNectin reagent also can be used to enhance T cell expansion in vitro.
¸»ÃÊÇ÷¾× ´ÜÇÙ¼¼Æ÷ (peripheral blood mononuclear cells; PBMCs)·ÎºÎÅÍ T ¸²ÇÁ±¸¸¦ È®´ë¹è¾çÇÒ ¶§ interleukin-2 (IL-2)¿Í anti-CD3 antibody¸¦ ÀÌ¿ëÇÑ´Ù. À̶§ RetroNectinÀ» ÀÌ¿ëÇϸé T cell È®´ë¹è¾ç È¿À²À» ºñ¾àÀûÀ¸·Î ³ôÀÌ°í, naive T cellÀÇ ºñÀ²ÀÌ ³ôÀº T cellÀ» È®º¸ÇÒ ¼ö ÀÖ´Ù. (Application Note PDF ´Ù¿î·Îµå)


±×¸². RetroNectin reagent (RN) increases expansion and naive T-cell fraction of PBMCs stimulated with anti-CD3 antibody and IL2. Peripheral blood T cells stimulated and expanded in vitro with anti-CD3 antibody (OKT3 clone) and IL2 for 10 days contained approximately twofold higher naive T cells (CD45RA+/CCR7+ phenotype) in the presence of immobilized RN than in the absence of RN.

RetroNectin¢ç GMP Grade Reagent for ex vivo Gene Therapy
RetroNectin GMP GradeÀº ÀÓ»ó½ÃÇè¿ëÀǾàÇ° (Investigational Product)À» À§ÇØ GMP °¡À̵å¶óÀÎÀ» ÁؼöÇÑ ½Ã¼³¿¡¼­ »ý»êµÈ °íÇ°Áú ½Ã¾àÀ¸·Î º°µµÀÇ ¹°Áú ÀÌÀü°è¾à (Materal Transfer Agreement; MTA)¾øÀÌ ex vivo ÀÓ»ó½ÃÇè¿¡ »ç¿ëÇÒ ¼ö ÀÖ´Ù.

[RetroNectin¢ç GMP Grade Reagent ÀÇ ÀÓ»ó È°¿ë ¿¹] (Application Note PDF ´Ù¿î·Îµå)
  • Adoptive Cell Therapy
  • T cell Immunotherapy for Acute Lymphoblastic Leukemia
  • T cell Expansion and Stimulation
  • Transduction of CD34+ Hematopoietic Stem Cells


±×¸². RetroNectin Reagent & Gene Therapy Research

¡Ø RetroNectin ±â¼úÀº ´ÙÄ«¶ó¹ÙÀÌ¿À°¡ µ¶Á¡À¸·Î º¸À¯ÇÏ°í Àִ ƯÇã±â¼ú·Î ÇöÀç °ø°ø ÀÇ·á±â°ü ¹× ¹Î°£ ±â¾÷¿¡¼­ ´Ù¾çÇÑ À¯ÀüÀÚÄ¡·áÀÇ ÀÓ»ó½ÃÇè¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ƯÈ÷ RetroNectin GMP Grade reagent´Â 44°³ ±â°ü, 68°Ç ÀÌ»óÀÇ À¯ÀüÀÚ Ä¡·á ÀÓ»ó½ÃÇè ÇÁ·ÎÅäÄÝ¿¡ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. RetroNectinÀ» ¿¬±¸ ¸ñÀû ÀÌ¿ÜÀÇ ¸ñÀûÀ¸·Î ½Ç½ÃÇÏ´Â °æ¿ì º°µµÀÇ ¶óÀ̼±½º °è¾àÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ´ÙÄ«¶óÄÚ¸®¾Æ °í°´Áö¿ø¼¾ÅÍ (02-2081-2510, support@takara.co.kr)·Î ¹®Àǹٶø´Ï´Ù.